Discovery and Mechanism of a Diiron Enzyme in Ethylidene Azetidine Formation
- PMID: 41081371
- PMCID: PMC12683556
- DOI: 10.1021/jacs.5c12910
Discovery and Mechanism of a Diiron Enzyme in Ethylidene Azetidine Formation
Erratum in
-
Correction to "Discovery and Mechanism of a Diiron Enzyme in Ethylidene Azetidine Formation".J Am Chem Soc. 2025 Nov 19;147(46):43198. doi: 10.1021/jacs.5c18214. Epub 2025 Nov 5. J Am Chem Soc. 2025. PMID: 41190445 No abstract available.
Abstract
Azetidine is a strained four-membered N-heterocycle that has important applications in medicinal chemistry and organic synthesis. Despite its relevance to human health and agriculture, azetidine biosynthesis remains largely unexplored. Herein, the DUF6202 family enzyme PolF is shown to utilize a diiron center and O2 to catalyze sequential desaturation and azetidination of l-isoleucine to yield the ethylidene azetidine moiety during the biosynthesis of polyoxin. Crystallographic analysis of PolF in complex with iron (or manganese) and l-isoleucine (or an alkene intermediate) reveals that it is a heme oxygenase-like diiron oxidase with a new iron-binding motif. Trapping an O2-bound intermediate in crystallo along with a distinctive iron-to-protein ratio observed under anoxic and aerobic environments indicates that binding of the second iron occurs in an O2-dependent manner. Mössbauer and stopped-flow optical absorption spectroscopy together with deuterium kinetic isotope effect measurements demonstrate that a μ-peroxodiiron(III) species is likely responsible for C-H bond activation. Mass Spectrometry analysis reveals that the decay of the μ-peroxodiiron(III) species is accompanied by the formation of a desaturated intermediate. Bioinformatic analysis identifies ca. 200 PolF homologues indicative of new biosynthetic pathways for azetidine-containing natural products.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Singh GS Advances in synthesis and chemistry of azetidines. Adv. Heterocycl. Chem 2020, 130, 1–74.
-
- Mughal H; Szostak M, Recent advances in the synthesis and reactivity of azetidines: strain-driven character of the four-membered heterocycle. Org. Biomol. Chem 2021, 19 (15), 3274–3286. - PubMed
-
- Pang L; Yao D; Gao F; Bian X; Zhang Y; Zhong G, Biosyntheses of azetidine-containing natural products. Org. Biomol. Chem 2023, 21 (36), 7242–7254. - PubMed
-
- Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG, Azetidines of pharmacological interest. Arch. Pharm 2021, 354 (11), e2100062. - PubMed
-
- Yan F; Auerbach D; Chai Y; Keller L; Tu Q; Huttel S; Glemser A; Grab HA; Bach T; Zhang Y; Muller R, Biosynthesis and Heterologous Production of Vioprolides: Rational Biosynthetic Engineering and Unprecedented 4-Methylazetidinecarboxylic Acid Formation. Angew. Chem. Int. Ed 2018, 57 (28), 8754–8759. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
